Results 191 to 200 of about 82,456 (226)

The Lupus Damage Index Revision Program: Results From the Item Generation and Reduction Phases

open access: yesArthritis Care &Research, Volume 78, Issue 10, Page 1449-1466, October 2026.
Objective A data‐driven and expert/patient consensus‐based project to develop a revised Systemic Lupus International Collaborating Clinics (SLICC)/American College of Rheumatology (ACR) Damage Index (SDI) is under way supported by SLICC, ACR, and the Lupus Foundation of America. Our objective is to report the item generation and reduction phase results
Burak Kundakci   +25 more
wiley   +1 more source

Geographic miss and stent graft restenosis in hemodialysis access. [PDF]

open access: yesRen Fail
Lien CW   +4 more
europepmc   +1 more source

Pediatric Superior Mesenteric Artery Syndrome: A Rare Case Report and Literature Review From Sudan

open access: yesClinical Case Reports, Volume 14, Issue 10, October 2026.
ABSTRACT A 10‐year‐old Sudanese boy with chronic bilious vomiting, cachexia, and scaphoid abdomen was diagnosed with Superior Mesenteric Artery Syndrome (SMAS) via CT angiography. After failed conservative management, side‐to‐side duodenojejunostomy resolved symptoms.
Alaa Yousif Yagoob Mohammed   +6 more
wiley   +1 more source

Standardized MRI‐Based Quantification of Epicardial Adipose Tissue Volume: Reproducibility and Agreement With Cardiac Computed Tomography

open access: yesJournal of Magnetic Resonance Imaging, Volume 64, Issue 4, Page 1052-1063, October 2026.
ABSTRACT Background Epicardial adipose tissue volume (EATV) is increasingly recognized as a cardiometabolic risk marker associated with adverse outcomes. The most established approach for EATV quantification is cardiac computed tomography (CT). MRI offers a radiation‐free alternative allowing simultaneous assessment of myocardial function and tissue ...
Judith Gronwald   +10 more
wiley   +1 more source

Hippo Pathway–YAP/TAZ Signaling: Molecular Mechanisms, Biological Function, Diseases, and Therapeutic Targets

open access: yesMedComm, Volume 7, Issue 10, October 2026.
The Hippo–YAP/TAZ–TEAD pathway integrates mechanical and biochemical cues to govern organ growth, regeneration, cancer, and fibrosis. This review dissects pathway physiology, TEAD structural pharmacology and ligandable pockets, and therapeutic strategies spanning palmitoylation‐pocket inhibitors, PROTAC degraders, and gene/RNA therapies, highlighting ...
Xiaodan Qu, Zhan‐you Wang
wiley   +1 more source

This ECG Does Not Fit: Rethinking Left Ventricular Hypertrophy. [PDF]

open access: yesJACC Case Rep
Perini Schweiger C   +9 more
europepmc   +1 more source

Impact of Diabetes on Management and Outcomes in Patients with Borderline FFRCT. [PDF]

open access: yesJ Cardiovasc Dev Dis
Chen Y   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy